Dutasteride (Avodart®) is an oral medication prescribed to treat an enlarged prostate. It may also be used off-label to treat male pattern hair loss.
Dutasteride
*image for illustrative purpose only
Dutasteride
*image for illustrative purpose only
Dutasteride is the active ingredient in the brand-name medication Avodart®, which is used to treat benign prostatic hyperplasia (BPH) by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), which helps shrink the prostate and improve urinary symptoms. Dutasteride works the same way as Avodart and has the same benefits and risks, per the FDA.
The drug is FDA-approved to treat BPH in men, and it may be used off-label for male pattern hair loss.
Avodart is available in capsule form. Common side effects include decreased libido, erectile dysfunction, and breast tenderness or enlargement, while drug interactions may occur with other medications that affect certain liver enzymes. It is contraindicated in people who can become pregnant due to the risk of birth defects, and it should not be handled by pregnant folks.
Avodart (dutasteride) is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to:
Improve symptoms
Reduce the risk of acute urinary retention
Reduce the risk of the need for BPH-related surgery
Avodart in combination with the alpha-adrenergic antagonist, tamsulosin, is indicated for the treatment of symptomatic BPH in men with an enlarged prostate
5 alpha-reductase inhibitor
The most common adverse reactions, reported in ≥1% of subjects treated with Avodart and more commonly than in subjects treated with placebo, are:
Impotence
Decreased libido
Ejaculation disorders
Breast disorders
The cost of dutasteride may vary depending on factors such as your insurance plan, the dosage, and where you buy it.
Without insurance, the average retail price of a month’s supply of dutasteride is about $168, but many coupons and discount cards are available, which may bring the price down as low as $1. Insurance plans may cover all or some of the cost of this medication.
You can get a prescription for dutasteride after being evaluated by your primary care provider or a specialist who can determine if the medicine is right for you based on factors like your symptoms and medical history.
Pregnancy
Patients with previously demonstrated, clinically significant hypersensitivity (e.g., serious skin reactions, angioedema) to Avodart or other 5 alpha-reductase inhibitors
Drug interactions: potent, chronic cytochrome P450 (CYP)3A4 enzyme inhibitors (e.g., ritonavir)
Avodart reduces serum prostate-specific antigen (PSA) concentration by approximately 50%
Avodart may increase the risk of high-grade prostate cancer
Prior to initiating treatment with Avodart, consideration should be given to other urological conditions that may cause similar symptoms
Women who are pregnant or may be pregnant should not handle Avodart capsules due to potential risk to a male fetus
Patients should not donate blood until 6 months after their last dose of Avodart
Other treatments for benign prostatic hyperplasia (BPH) include:
Proscar® (finasteride), another 5-alpha reductase inhibitor
Alpha-blockers:
Uroxatral® (alfuzosin)
Cardura® (doxazosin)
Rapaflo® (silodosin)
Flomax® (tamsulosin)
Terazosin
Combination therapies
Surgery
Options available for male pattern hair loss — some of which may be better than others — include:
Oral minoxidil (prescribed off-label at the discretion of a healthcare provider)
Platelet-rich plasma therapy for hair loss
Targeted hair care products such as thickening shampoo
Topical finasteride and minoxidil spray (prescribed at the discretion of a healthcare provider
Biotin and other hair-growth supplements
Research shows that both dutasteride and finasteride effectively reduce hair loss, but some studies suggest dutasteride is slightly better at blocking dihydrotestosterone (DHT), a hormone linked to hair loss in men, and encouraging thicker hair growth. However, only finasteride is FDA-approved to treat hair loss, while dutasteride may be prescribed off-label.
Dutasteride is FDA-approved to treat BPH, but not enough research has been done to support its approval for hair loss in men.
Yes, it can. Dutasteride’s side effects may include erectile dysfunction, decreased libido, and problems with ejaculation.
Yes, in certain cases. Dutasteride is not prescribed to women who are pregnant or can become pregnant because it can cause birth defects. However, it may be prescribed off-label for female pattern hair loss. In one study of women with female pattern hair loss who took dutasteride for three years, the drug effectively increased their hair thickness and stopped further hair loss.
*This information is from the label for brand name Avodart®. See the Full Prescribing Information for more complete information. Dutasteride, the active ingredient in Avodart, may also be the active ingredient in other medications, and this information may not be accurate for all medications that include the active ingredient dutasteride.
Al-Horani RA, et al. (2024). Dutasteride: StatPearls: NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK603726/
American Society of Plastic Surgeons. (n.d.). Hair Transplantation and Restoration. https://www.plasticsurgery.org/cosmetic-procedures/hair-transplantation-and-restoration
Boersma IH, et al. (2014). The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia. https://ijdvl.com/the-effectiveness-of-finasteride-and-dutasteride-used-for-3-years-in-women-with-androgenetic-alopecia/
GoodRx. (n.d.). Dutasteride prices, coupons, and savings tips. https://www.goodrx.com/dutasteride
Haile ES, et al. (2024). Medical management of benign prostatic hyperplasia. https://www.ccjm.org/content/91/3/163
International Society of Hair Restoration Surgery. (n.d.). Scalp micropigmentation (SMP): all you need to know. https://ishrs.org/micropigmentation-of-scalp/
National Library of Medicine. (2024). Dutasteride: MedlinePlus drug information. https://medlineplus.gov/druginfo/meds/a603001.html
Paichitrojjana A, et al. (2022). Platelet rich plasma and its use in hair regrowth: a review. https://pmc.ncbi.nlm.nih.gov/articles/PMC8922312/